CN Stock MarketDetailed Quotes

688488 Jiangsu Aidea Pharmaceutical

Watchlist
  • 9.62
  • +0.03+0.31%
Market Closed Dec 13 15:00 CST
4.05BMarket Cap-38.79P/E (TTM)

About Jiangsu Aidea Pharmaceutical Company

The company was founded in 2009 and listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange in 2020. The company takes anti-AIDS drugs as its core development field, and at the same time leverages its competitive advantage in the field of human protein, and actively explores, develops and sells innovative drugs guided by unmet domestic clinical diagnosis and treatment needs. The company's main business focuses on the fields of anti-HIV and human protein. The company's main products include products in the field of anti-HIV, pharmaceuticals in the field of human protein, and products in the field of anti-cancer. Corporate honors: It won the title of “2019-2020 Yangzhou Civilized Unit”, the crude product of human urinary kinin peptide enzyme was certified as a high-tech product in Jiangsu Province in 2014, and the first-class anti-AIDS drug ACC007 was included in the “Major New Drug Creation” science and technology project of the 13th Five-Year Plan.

Company Profile

Short Name-A艾迪药业
Company NameJiangsu Aidea Pharmaceutical Co.,Ltd.
Listing DateJul 20, 2020
Issue Price13.99
Shares Offered60.00M share(s)
FoundedDec 15, 2009
Chairmanheliang fu
Legal Representativeheliang fu
General Managerjie zhang
Secretaryyan liu
Employees476
ProvinceJiang Su Sheng
Phone0514-82090238
Office AddressNo. 69, Xinganquan West Road, Hanjiang District, Yangzhou
Zip Code225008
Registered AddressNo. 69, Xinganquan West Road, Hanjiang District, Yangzhou City, Jiangsu Province
Fax0514-87736366
Emailad@aidea.com.cn
Business License913210006979433664
BusinessPharmaceutical research and development, drug production and sales; development, acquisition, processing and sales of human urine protein, animal organs, and active ingredients from plant raw materials; technology research and development and transfer, technical consulting and technical services; self-employment and agency of general commodities and technology import and export operations (not involving state-owned trade management products; applications involving quotas and license management products are processed in accordance with relevant national regulations). (The scope of business does not include projects where the country implements special administrative measures for foreign investment entry. Projects requiring approval according to law can only be carried out after approval by relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • heliang fu
  • Chairman, Directors, Core Technical Personnel
  • --
  • xiaoyan qi
  • Independent Directors
  • 100.00K
  • guangji wang
  • Independent Directors
  • 100.00K
  • zijian guo
  • Independent Directors, Remuneration and Assessment Committee Convener
  • 29.40K
  • yan liu
  • Board Secretary
  • 679.70K
  • weixuan zhou
  • Securities Affairs Representative
  • --
  • fengying he
  • Auditors
  • 759.30K
  • Hong Qi
  • Senior Vice President, Chief Technology Officer
  • 1.11M
  • jun wang
  • Vice Loader, Production Manager
  • 872.80K
  • hong qin
  • VP, Chief Medical Officer
  • 2.46M
  • gaohong gu
  • Senior Vice President
  • 319.30K
  • chuanhong zhu
  • Chief Financial Officer
  • 214.30K
  • qian zhao
  • Head of Internal Audit and Supervision Department
  • --
  • kangkang han
  • Head of Internal Audit and Supervision Department
  • --
  • heng yu
  • Core technical personnel, Plant manager (pharmaceuticals)
  • 720.80K
  • jibing zhang
  • Core technical personnel, Plant manager (human protein)
  • 826.30K
  • gufang su
  • Core Technical Personnel, Raw Material Workshop Manager
  • 483.40K
  • yu yuan
  • Core Technical Personnel, Director of Human Protein Technology Center
  • --
  • jie zhang
  • Chief Operating Officer
  • 3.01M
  • haiwang ji
  • Employee Supervisors
  • 50.20K
Heat List
CN
Overall
Symbol
Price
% Chg

No Data